Livongo Health says second-quarter rose 156% from a year earlier to $40.9 million.
The Nashville provider of teeth-straightening technology will have a dual class of shares, with the CEO controlling the voting power.
No company is safe from the litigation risk tied to the drug epidemic, but Johnson & Johnson may be one of the few guaranteed to survive.
IDEXX Laboratories and Zoetis Inc. appear ready to trade higher, offering stable opportunities as the dog-eat-dog trade war lingers on.
I am not focused on today's price movement of the stock but the pattern from the end of 2017.
Sign up to get started or log in to see your watchlist.
Enter a symbol above to add it to your watchlist.
A confirmation email has been sent to the address provided during registration. Please click on the appropriate link to confirm your email address.